20 results
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... Treatment Agents ... 2020 #Drugs #Medications ... #Pharmacology # ... Table #Management
AACE/ACE 2016 Postmenopausal Osteoporosis Treatment Algorithm

Evaluate for causes of secondary osteoporosis

Correct calcium/vitamin D deficiency and address
Evaluate for causes ... deficiency and address causes ... • Recommend pharmacologic ... measures, fall prevention ... benefits and risks of medications
This is an overview of the 3 main drug classes used to treat Hepatitis C

The new
This is an overview ... the 3 main drug classes ... patients genotype, treatment ... ambcarerx #HCV #Medications ... #DAAs #Pharmacology
Intern Pocket Cards - Inpatient Anti-Emetics Guide
Serotonin antagonists:
 • Ondansetron (Zofran), Granisetron (Kytril, Sancuso) - Headache,
xerostomia, urinary retention ... pocketcardset #nausea ... antiemetics #vomiting #medications ... #pharmacology # ... table #agents #internship
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... Encephalitis in HIV-AIDS Indications ... CD4 count <100 cells ... #Treatment #opportunistic ... #pharmacology
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
Aplastic Anemia - Overview ... and petechiae Causes ... - Antithyroid medications ... number of CD34+ cells ... aplastic anemia Treatment
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
emphasis placed on prevention ... the determined cause ... then placed on prevention ... #table #foamed ... icu #clinical #pharmacology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
Kidney stones caused ... nocturnal enuresis • Prevention ... Tolvaptan) • Treatment ... Diuresis #Nephrology #Pharmacology ... #Medications #Table
Cauda Equina Syndrome Overview

Cauda Equina Syndrome:
 • Prevalence: 1:33,000-100,000 ppl/yr
 • Incidence: 1.5-3.4 million ppl/yr
 •
Equina Syndrome Overview ... characterized by these so-called ... - Emergency Causes ... axial T1 and T2 Treatment ... differential #diagnosis #causes
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
Etiology: • Medications ... only if no clear cause ... Elimination (see Table ... STOP offending medications ... Drives K+ into cells